Select Medical Holdings Corporation

NYSE:SEM Lagerbericht

Marktkapitalisierung: US$4.9b

Select Medical Holdings Management

Management Kriterienprüfungen 1/4

Select Medical Holdings CEO ist David Chernow , ernannt in Jan 2014, hat eine Amtszeit von 10.83 Jahren. Die jährliche Gesamtvergütung beträgt $10.71M , bestehend aus 9.3% Gehalt und 90.7% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.73% der Aktien des Unternehmens, im Wert von $35.79M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 1.1 Jahre bzw. 14.5 Jahre.

Wichtige Informationen

David Chernow

Geschäftsführender

US$10.7m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts9.3%
Amtszeit als Geschäftsführer10.8yrs
Eigentum des Geschäftsführers0.7%
Durchschnittliche Amtszeit des Managements1.1yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder14.5yrs

Jüngste Management Updates

Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Apr 19
Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Recent updates

Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125

Nov 04
Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125

Returns Are Gaining Momentum At Select Medical Holdings (NYSE:SEM)

Oct 21
Returns Are Gaining Momentum At Select Medical Holdings (NYSE:SEM)

Select Medical Holdings: No Reason To Downgrade This One Just Yet

Oct 07

Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?

Oct 03
Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?

Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125

Aug 05
Select Medical Holdings' (NYSE:SEM) Dividend Will Be $0.125

Select Medical Holdings' (NYSE:SEM) Returns On Capital Are Heading Higher

Jul 19
Select Medical Holdings' (NYSE:SEM) Returns On Capital Are Heading Higher

What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Jul 01
What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?

Jun 13
Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?

There's Reason For Concern Over Select Medical Holdings Corporation's (NYSE:SEM) Price

May 26
There's Reason For Concern Over Select Medical Holdings Corporation's (NYSE:SEM) Price

Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

May 05
Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Apr 19
Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Apr 11
Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Select Medical: Solid Growth Prospects And A Compelling Valuation

Mar 05

Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely

Feb 18
Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely

We Think Select Medical Holdings (NYSE:SEM) Is Taking Some Risk With Its Debt

Jan 15
We Think Select Medical Holdings (NYSE:SEM) Is Taking Some Risk With Its Debt

Returns On Capital At Select Medical Holdings (NYSE:SEM) Have Hit The Brakes

Dec 31
Returns On Capital At Select Medical Holdings (NYSE:SEM) Have Hit The Brakes

Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125

Nov 06
Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125

Select Medical: Market Expectations Appear Well Justified With Technical And Economic Factors

Oct 25

What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Oct 04
What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Is Select Medical Holdings (NYSE:SEM) Using Too Much Debt?

Sep 16
Is Select Medical Holdings (NYSE:SEM) Using Too Much Debt?

Select Medical: Capital Charge Now $6.1Bn At C.6% Trailing Returns, Reiterate Hold

Aug 11

Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of $0.125

Aug 07
Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of $0.125

Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward

Jul 14
Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward

At US$31.69, Is Select Medical Holdings Corporation (NYSE:SEM) Worth Looking At Closely?

Jun 29
At US$31.69, Is Select Medical Holdings Corporation (NYSE:SEM) Worth Looking At Closely?

Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

May 27
Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

Select Medical: Revising To Hold As Business Economics Roll Lower

May 26

Select Medical Holdings (NYSE:SEM) May Have Issues Allocating Its Capital

Apr 05
Select Medical Holdings (NYSE:SEM) May Have Issues Allocating Its Capital

Should You Investigate Select Medical Holdings Corporation (NYSE:SEM) At US$25.73?

Mar 17
Should You Investigate Select Medical Holdings Corporation (NYSE:SEM) At US$25.73?

Select Medical GAAP EPS of $0.22 misses by $0.11, revenue of $1.58B in-line

Feb 23

Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

Jan 31
Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

The Returns On Capital At Select Medical Holdings (NYSE:SEM) Don't Inspire Confidence

Dec 20
The Returns On Capital At Select Medical Holdings (NYSE:SEM) Don't Inspire Confidence

Is Now An Opportune Moment To Examine Select Medical Holdings Corporation (NYSE:SEM)?

Dec 01
Is Now An Opportune Moment To Examine Select Medical Holdings Corporation (NYSE:SEM)?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von David Chernow im Vergleich zu den Einnahmen von Select Medical Holdings verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2024n/an/a

US$266m

Jun 30 2024n/an/a

US$259m

Mar 31 2024n/an/a

US$260m

Dec 31 2023US$11mUS$995k

US$235m

Sep 30 2023n/an/a

US$217m

Jun 30 2023n/an/a

US$196m

Mar 31 2023n/an/a

US$174m

Dec 31 2022US$9mUS$995k

US$153m

Sep 30 2022n/an/a

US$175m

Jun 30 2022n/an/a

US$223m

Mar 31 2022n/an/a

US$329m

Dec 31 2021US$12mUS$995k

US$389m

Sep 30 2021n/an/a

US$415m

Jun 30 2021n/an/a

US$415m

Mar 31 2021n/an/a

US$306m

Dec 31 2020US$8mUS$995k

US$250m

Sep 30 2020n/an/a

US$206m

Jun 30 2020n/an/a

US$162m

Mar 31 2020n/an/a

US$155m

Dec 31 2019US$8mUS$995k

US$143m

Sep 30 2019n/an/a

US$136m

Jun 30 2019n/an/a

US$138m

Mar 31 2019n/an/a

US$140m

Dec 31 2018US$8mUS$995k

US$133m

Sep 30 2018n/an/a

US$207m

Jun 30 2018n/an/a

US$193m

Mar 31 2018n/an/a

US$189m

Dec 31 2017US$7mUS$984k

US$171m

Vergütung im Vergleich zum Markt: DavidDie Gesamtvergütung ($USD10.71M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD7.94M).

Entschädigung vs. Einkommen: DavidDie Bezüge der Mitarbeiter sind im vergangenen Jahr um mehr als 20 % gestiegen.

Geschäftsführer

David Chernow (67 yo)

10.8yrs

Amtszeit

US$10,706,265

Vergütung

Mr. David S. Chernow serves as Director at Exokinetics, Inc. He has been the Chief Executive Officer at Select Medical Holdings Corporation and Select Medical Corporation since January 1, 2014. Mr. Chernow...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Robert Ortenzio
Co-Founder & Executive Chairman19.8yrsUS$10.77m6.94%
$ 341.0m
David Chernow
Chief Executive Officer10.8yrsUS$10.71m0.73%
$ 35.8m
Michael Malatesta
Executive VP & CFO1.1yrsUS$1.53m0.13%
$ 6.5m
Michael Tarvin
Senior Executive VP27.8yrsUS$4.44m0.34%
$ 16.6m
Martin Jackson
Senior Executive Vice President of Strategic Finance & Operations1.1yrsUS$6.47m0.99%
$ 48.5m
John Saich
Co-President1.1yrskeine Daten0.51%
$ 25.1m
Thomas Mullin
Co-President1.1yrskeine Daten0.24%
$ 12.0m
Christopher Weigl
Senior VP1.7yrskeine Daten0.027%
$ 1.3m
Brian Rusignuolo
Executive VP & Chief Information Officer3.8yrskeine Daten0.23%
$ 11.5m
Robert Breighner
Senior Vice President of Compliance & Auditno datakeine Daten0.027%
$ 1.3m
Shelly Eckenroth
Senior VP & Chief Communications1.1yrskeine Datenkeine Daten
Mary Lacey
Senior VP & Chief Human Resources Officer1.1yrskeine Datenkeine Daten

1.1yrs

Durchschnittliche Betriebszugehörigkeit

55yo

Durchschnittliches Alter

Erfahrenes Management: SEMDas Führungsteam des Unternehmens gilt nicht als erfahren ( 1.1 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Robert Ortenzio
Co-Founder & Executive Chairman19.8yrsUS$10.77m6.94%
$ 341.0m
Russell Carson
Independent Lead Director19.8yrsUS$384.40k0.85%
$ 41.7m
Thomas Scully
Independent Director20.8yrsUS$383.40k0.069%
$ 3.4m
Daniel Thomas
Independent Director5.3yrsUS$405.80k0.051%
$ 2.5m
William Frist
Independent Director14.5yrsUS$407.83k0.22%
$ 10.9m
Marilyn Tavenner
Independent Director6yrsUS$394.40k0.042%
$ 2.1m
James Ely
Independent Director16yrsUS$414.83k0.11%
$ 5.6m
Katherine Davisson
Independent Director3.6yrsUS$409.80k0.036%
$ 1.8m
Parvinderjit Khanuja
Independent Director3yrsUS$407.83k0.034%
$ 1.7m

14.5yrs

Durchschnittliche Betriebszugehörigkeit

66yo

Durchschnittliches Alter

Erfahrener Vorstand: SEMDie Vorstandsmitglieder sind sehr erfahren ( 14.5 ).